Rebecca M Davidson
Overview
Explore the profile of Rebecca M Davidson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
2449
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Epperson L, Davidson R, Kammlade S, Hasan N, Nick S, Machado I, et al.
Diagn Microbiol Infect Dis
. 2024 Sep;
110(4):116526.
PMID: 39293318
Pulmonary nontuberculous mycobacteria (NTM) disease is an emerging public health challenge that is especially problematic in people with cystic fibrosis (CF). Effective treatment depends on accurate species and subspecies identification...
2.
Baker A, Nick S, Jia F, Graves A, Warren B, Zavala S, et al.
J Clin Microbiol
. 2024 May;
62(6):e0014924.
PMID: 38690881
We identified 23 cases of respiratory acquisition linked to a colonized plumbing system at a new hospital addition. We conducted a genomic and epidemiologic investigation to assess for clonal acquisition...
3.
Gross J, Caceres S, Poch K, Epperson L, Hasan N, Jia F, et al.
PLoS One
. 2023 Dec;
18(12):e0291910.
PMID: 38117792
Background: Healthcare-associated acquisition and transmission of nontuberculous mycobacteria (NTM) among people with cystic fibrosis (pwCF) has been described, and remains a concern for both patients and providers. This report describes...
4.
Jia F, Nick S, Davidson R, Baker A
Microbiol Resour Announc
. 2023 Nov;
12(12):e0061823.
PMID: 37943039
is a rapidly growing nontuberculous mycobacteria species that can cause healthcare-associated infections. We report the complete genome of C14-1.MIM, isolated via culture of a respiratory specimen obtained from a hospitalized...
5.
Wynn E, Dide-Agossou C, Reichlen M, Rossmassler K, Al Mubarak R, Reid J, et al.
mBio
. 2023 Oct;
14(6):e0236323.
PMID: 37905920
A major reason that curing tuberculosis requires prolonged treatment is that drug exposure changes bacterial phenotypes. The physiologic adaptations of that survive drug exposure have been obscure due to low...
6.
Martiniano S, Caceres S, Poch K, Rysavy N, Lovell V, Armantrout E, et al.
J Cyst Fibros
. 2023 Sep;
23(1):50-57.
PMID: 37666709
Background: Nontuberculous mycobacteria (NTM) are an important cause of airway infections in people with cystic fibrosis (pwCF). Isolation of NTM from respiratory specimens of pwCF do not mandate treatment in...
7.
Wynn E, Dide-Agossou C, Reichlen M, Rossmassler K, Al Mubarak R, Reid J, et al.
bioRxiv
. 2023 Mar;
PMID: 36945388
Transcriptome evaluation of in the lungs of laboratory animals during long-term treatment has been limited by extremely low abundance of bacterial mRNA relative to eukaryotic RNA. Here we report a...
8.
Gross J, Teneback C, Sweet J, Caceres S, Poch K, Hasan N, et al.
Ann Am Thorac Soc
. 2023 Jan;
20(5):677-686.
PMID: 36656594
Outbreaks of nontuberculous mycobacteria (NTM) among people with cystic fibrosis (pwCF) have been reported at CF centers with conflicting conclusions. The occurrence of NTM at the UVMC (University of Vermont...
9.
Nick J, Malcolm K, Hisert K, Wheeler E, Rysavy N, Poch K, et al.
Tuberculosis (Edinb)
. 2022 Nov;
138:102276.
PMID: 36417800
Nontuberculous mycobacteria (NTM) are opportunistic pathogens that affect a relatively small but significant portion of the people with cystic fibrosis (CF), and may cause increased morbidity and mortality in this...
10.
Dedrick R, Smith B, Cristinziano M, Freeman K, Jacobs-Sera D, Belessis Y, et al.
Clin Infect Dis
. 2022 Jun;
76(1):103-112.
PMID: 35676823
Background: Nontuberculous Mycobacterium infections, particularly Mycobacterium abscessus, are increasingly common among patients with cystic fibrosis and chronic bronchiectatic lung diseases. Treatment is challenging due to intrinsic antibiotic resistance. Bacteriophage therapy...